iiinova — where your digital self keeps evolving

Reposted by Aatur Singhi, MD PhD

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 24/06/2025

New Journal for ImmunoTherapy of Cancer article: Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma bit.ly/4lcxHLC ‪ @riyuesunnybao.bsky.social @pancpathologist.bsky.social ‪ @zervanto.bsky.social @jasonlukemd.bsky.social #JITC #cancer #MedSky

032

Reposted by Aatur Singhi, MD PhD

Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 05/05/2025

🔥 Great discussion at the in person meeting of the GLOBAL GUIDELINES FOR CYSTIC TUMORS OF THE PANCREAS expected to be released 🔜 stay tuned! @letswinpc.org #HPBSky

083

Reposted by Aatur Singhi, MD PhD

Denis Wirtz @deniswirtz.bsky.social · 28/04/2025

A huge majority of Americans (77%) oppose the cuts to medical research that the current administration has made. (Source: Wash. Post/ABC/Ipsos poll)

310741

Aatur Singhi, MD PhD @pancpathologist.bsky.social · 27/04/2025

A little late, but what a wonderful time supporting #PancreaticCancer research at @pancan.bsky.social purplestride in Pittsburgh. @news.upmc.com @upmc.com @upmchillmancc.bsky.social

140

Reposted by Aatur Singhi, MD PhD

Pancreatic Cancer Action Network @pancan.bsky.social · 10/04/2025

If you or someone you love has been diagnosed with #pancreaticcancer, you’re not alone — we’re here to help. 💜 Our educational packets include essential resources to help you navigate next steps. Access these materials digitally 🖥️ or have them mailed to you 📬 by visiting pcan.at/skpmuj.

021

Reposted by Aatur Singhi, MD PhD

Denis Wirtz @deniswirtz.bsky.social · 26/03/2025

This is catastrophic for pancreatic cancer patients

414478

Aatur Singhi, MD PhD @pancpathologist.bsky.social · 22/03/2025

Truly unfortunate. But great image. Would love to evaluate by whole transcriptome to see differences between these neoplasms as opposed to conventional CRC have...

000

Reposted by Aatur Singhi, MD PhD

UPMCnews @news.upmc.com · 21/03/2025

In HER2-positive early #breastcancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival Check out the full story 👇 www.curetoday.com/view/kadcyla...

curetoday.com

Kadcyla Continues to Show Benefits in Early HER2+ Breast Cancer

In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.

011

Reposted by Aatur Singhi, MD PhD

Pancreatic Cancer Action Network @pancan.bsky.social · 16/03/2025

Our incredible Team PanCAN runners are lacing up for the LA Marathon and Charity Half Marathon, and the United Airlines NYC Half Marathon today! 💜🏃‍♂️ They’ve spent months training and fundraising to make a difference for pancreatic cancer patients. Let’s show them some love in the comments!

041

Reposted by Aatur Singhi, MD PhD

Dr Elliot K Fishman | CTisus.com @ctisus.bsky.social · 23/12/2024

Serous Cystadenoma HOP with Vascular Map

022

Reposted by Aatur Singhi, MD PhD

Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 19/12/2024

💥 A Stellar episode of our virtual meeting on pancreas topic.. this time IPMN 🍇 !!! 🚨 Integrating molecular testing to the evaluation of Pancreatic Cyst with the great @pancpathologist.bsky.social 🇺🇸 @upmc.bsky.social Thank you, Aatur Singhi, for such a Christmas gift!!! 🎄 youtu.be/fF7HcPCqiwk

youtu.be

Integrating molecular testing to the evaluation of Pancreatic Cysts

YouTube video by Padova Pancreas Club

172

Reposted by Aatur Singhi, MD PhD

Dr Elliot K Fishman | CTisus.com @ctisus.bsky.social · 29/11/2024

Benign Pancreatic Tumors Read more here: ctisus.com/learning/fea...

073

Reposted by Aatur Singhi, MD PhD

Julie Hallet, MD MSc @halletjulie.bsky.social · 27/11/2024

More data on role of ATRX/DAXX loss for surgery in pancreas #NETs 👥116 PNETs in 🇯🇵 🧬11% DAXX & 7% ATRX loss 👉🏻intratumoral heterogeneity in 1/3 ⬇️RFS with ATRX/DAXX loss Should it be done routinely on all PNETs? 🔗 pubmed.ncbi.nlm.nih.gov/38909708/ #NETsSky #HPBSky #SurgSky #PancSky

042

Reposted by Aatur Singhi, MD PhD

Dr Elliot K Fishman | CTisus.com @ctisus.bsky.social · 26/11/2024

PNET: CT Findings ctisus.com/learning/fea...

083

Reposted by Aatur Singhi, MD PhD

Dr Elliot K Fishman | CTisus.com @ctisus.bsky.social · 26/11/2024

Pancreatic Paraganglioma: CT Findings ctisus.com/learning/fea...

032

Reposted by Aatur Singhi, MD PhD

Thor Halfdanarson @oncothor.bsky.social · 16/11/2024

Is the other ALT (alternative lengthening of telomeres) ready for use in pNETs..? I think so, especially for prognostication after resection. Chromogenic ISH (CISH) easier to implement than FISH. Excellent stuff from Chris Heaphy, Aatur Singhi et al. www.sciencedirect.com/science/arti...

sciencedirect.com

Detection of Alternative Lengthening of Telomeres via Chromogenic in situ Hybridization (ALT-CISH) for the Prognostication of PanNETs and Other Neoplasms

Molecular studies have shown ALT to be an important prognostic biomarker of shorter relapse-free survival (RFS) for patients with pancreatic neuroendo…

031